Genetics News and Research RSS Feed - Genetics News and Research Twitter

Genetics is the study of genes and heredity. Heredity is the passing of genetic information and traits (such as eye color and an increased chance of getting a certain disease) from parents to offspring.
Prof. Mary-Claire King receives 2014 Lasker-Koshland Special Achievement Award in Medical Science

Prof. Mary-Claire King receives 2014 Lasker-Koshland Special Achievement Award in Medical Science

At a ceremony held in New York City on September 19, 2014, leading geneticist and humanitarian Prof. Mary-Claire King, the American Cancer Society Professor of Genome Sciences and Medicine at the University of Washington in Seattle and 2008 Honorary Doctor of Philosophy of Tel Aviv University, was awarded the 2014 Lasker-Koshland Special Achievement Award in Medical Science. [More]
Efforts to roll back school nutritional standards could jeopardize gains made against childhood obesity

Efforts to roll back school nutritional standards could jeopardize gains made against childhood obesity

Efforts to roll back current nutritional standards for the National School Lunch Program could jeopardize gains made in the fight against childhood obesity, write the authors of an article that will appear in the November 13 New England Journal of Medicine and has been released online. [More]
Biology influences political ideology, find Virginia Tech scientists

Biology influences political ideology, find Virginia Tech scientists

Maggot infestations, rotting carcasses, unidentifiable gunk in the kitchen sink – how much your brain responds to disgusting images could predict whether you are liberal or conservative. [More]
New study reveals link between aristolochic acid and kidney cancer

New study reveals link between aristolochic acid and kidney cancer

A new study on a large cohort of kidney cancer patients in Europe sheds light on the genetic architecture of the disease -- and reveals an apparent link between exposure to aristolochic acid and incidence of kidney cancer, particularly in Romania. [More]
UCSD researchers validate EEG test to study, treat schizophrenia

UCSD researchers validate EEG test to study, treat schizophrenia

Researchers at University of California, San Diego School of Medicine have validated an EEG test to study and treat schizophrenia. The findings, published in two separate studies, offer a clinical test that could be used to help diagnose persons at risk for developing mental illness later in life, as well as an approach for measuring the efficacies of different treatment options. [More]
Genetic differences contribute to risk for autism

Genetic differences contribute to risk for autism

Small differences in as many as a thousand genes contribute to risk for autism, according to a study led by Mount Sinai researchers and the Autism Sequencing Consortium, and published today in the journal Nature. [More]
Researchers find potential target for therapies to treat cocaine addiction

Researchers find potential target for therapies to treat cocaine addiction

A study led by investigators from Massachusetts General Hospital and the Perelman School of Medicine at the University of Pennsylvania has identified a potential target for therapies to treat cocaine addiction. [More]
Same cell type can give rise to different gliomas

Same cell type can give rise to different gliomas

Glioma is a common name for serious brain tumours. Different types of glioma are usually diagnosed as separate diseases and have been considered to arise from different cell types in the brain. [More]
Ugandans lack knowledge about stroke

Ugandans lack knowledge about stroke

A study published in the journal International Scholarly Research Notices Stroke found that overall knowledge about stroke in Uganda was poor, although knowing what to do for a stroke – go to the hospital – was good. [More]
GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

GenomOncology today announced that University Hospitals Case Medical Center and UH Seidman Cancer Center (Cleveland, Ohio) have selected the company's GO Clinical Workbench to launch a clinical cancer product. UH will leverage the GO Clinical Workbench for workflow management from raw sequencing data through delivery of an actionable clinical report for oncologists. [More]
RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Scientists say they have identified in about 20 percent of colorectal and endometrial cancers a genetic mutation that had been overlooked in recent large, comprehensive gene searches. With this discovery, the altered gene, called RNF43, now ranks as one of the most common mutations in the two cancer types. [More]
Salk Institute scientists identify promising target for HIV/AIDS treatment

Salk Institute scientists identify promising target for HIV/AIDS treatment

Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system. [More]
InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS). [More]
WHO holds meeting to discuss on how to fast track testing, deployment of Ebola vaccines

WHO holds meeting to discuss on how to fast track testing, deployment of Ebola vaccines

WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic. [More]
Study suggests that objective hearing tests need to be refined for teenagers at risk for hearing loss

Study suggests that objective hearing tests need to be refined for teenagers at risk for hearing loss

Subjective screening questions do not reliably identify teenagers who are at risk for hearing loss, according to researchers at Penn State College of Medicine. The results suggest that objective hearing tests should be refined for this age group to replace screening questions. [More]
UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

Genetic screening services for rural and underserved populations will expand from six to 22 counties in North Texas under a $1.5 million grant from the Cancer Prevention and Research Institute of Texas to UT Southwestern Medical Center. [More]
High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

Down syndrome is the most common chromosomal abnormality in humans, involving a third copy of all or part of chromosome 21. In addition to intellectual disability, individuals with Down syndrome have a high risk of congenital heart defects. However, not all people with Down syndrome have them – about half have structurally normal hearts. [More]
MIT researchers develop new way to model effects of cancer-causing genetic mutations

MIT researchers develop new way to model effects of cancer-causing genetic mutations

Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process. [More]
French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

The Hospices Civils de Lyon, the second-largest University Hospital Network in France, has elected to use the Sophia Genetics Data Driven Medicine (DDM) Platform to support improvements in diagnostic testing for patients suffering from congenital disorders. [More]
Human trial of second investigational Ebola vaccine candidate under way

Human trial of second investigational Ebola vaccine candidate under way

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health's Clinical Center in Bethesda, Maryland. [More]